bioAffinity Technologies Enters Material Definitive Agreement
Ticker: BIAFW · Form: 8-K · Filed: May 27, 2025 · CIK: 1712762
Sentiment: neutral
Topics: material-agreement, 8-k
Related Tickers: BIAF
TL;DR
BIAF signed a big deal, filing 8-K on 5/27.
AI Summary
On May 22, 2025, bioAffinity Technologies, Inc. entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive offices in San Antonio, Texas, filed this 8-K report on May 27, 2025. The filing details the entry into this significant agreement.
Why It Matters
This filing indicates a significant development for bioAffinity Technologies, Inc., potentially impacting its operations and future business strategies.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the nature of this agreement is not detailed in the provided excerpt.
Key Numbers
- 001-41463 — SEC File Number (Identifies the company's filing history with the SEC.)
- 46-5211056 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- bioAffinity Technologies, Inc. (company) — Registrant
- May 22, 2025 (date) — Date of earliest event reported
- May 27, 2025 (date) — Filing date
- San Antonio, Texas (location) — Principal executive offices
- Delaware (location) — State of incorporation
FAQ
What is the nature of the material definitive agreement entered into by bioAffinity Technologies, Inc. on May 22, 2025?
The provided excerpt does not specify the details of the material definitive agreement.
What is the primary business of bioAffinity Technologies, Inc.?
bioAffinity Technologies, Inc. is in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector, SIC code 8731.
When was this 8-K filing submitted to the SEC?
The filing was submitted on May 27, 2025.
Where are bioAffinity Technologies, Inc.'s principal executive offices located?
The principal executive offices are located at 3300 Nacogdoches Road, Suite 216, San Antonio, Texas 78217.
What is the company's state of incorporation?
The company is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 27, 2025 regarding bioAffinity Technologies, Inc. (BIAFW).